Dan Pitulia

Dan Pitulia is a seasoned executive with extensive experience in leading and transforming companies across the medical and technology sectors. Currently serving as Chief Executive Officer at Atlas Antibodies since March 2025, Dan Pitulia also contributes as a Board Member at QleanAir Scandinavia AB and a Senior Business Advisor at Xaga Surgical. Additionally, Dan Pitulia holds the position of Chairman at Neoventa Medical and previously served as CEO and Non-Executive Director at Coala Life, where efforts focused on real-time heart monitoring. Prior notable roles include Chairman at Memira, leading the company to a successful sale to Bergman Clinics, and CEO positions at Carmel Pharma and Entific Medical Systems, both of which achieved significant global growth and were ultimately sold. Dan Pitulia's career reflects a consistent track record of driving company turnaround, transformation, and international expansion, supported by a Bachelor's degree in International Business from the Stockholm School of Economics.